BoNT Antibodies

Santa Cruz Biotechnology features a diverse variety of BoNT Antibodies for the detection and characterization of botulinum neurotoxin proteins. BoNT Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Botulinum neurotoxin is a potent neurotoxin produced by the bacterium Clostridium botulinum, and it plays a significant role in both medical and research settings due to its ability to inhibit neurotransmitter release, leading to muscle paralysis. Understanding the mechanisms of botulinum neurotoxin is essential for developing therapeutic strategies for conditions such as muscle spasticity and chronic pain. The study of BoNT is also crucial for public health, as it is associated with foodborne illnesses. BoNT research continues to reveal new insights into neurotransmitter release mechanisms and potential therapeutic applications. Ongoing investigations focus on understanding the structure-function relationships of BoNT and its interactions with cellular targets. Research utilizing BoNT has led to breakthroughs in treating various neurological and muscular disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing neurobiology and toxin research, contributing to scientific progress and therapeutic developments.